Boston Business Journal Report: FDA Accuses Biogen, Shire of ‘Gaming Tactics'

Biotech and higher education reporter Max Stendahl joins necn to discuss his story, “Biogen, Shire called out by FDA for ‘gaming’ generic access rule.”